Cargando…

Intragenic DOK7 deletion detected by whole-genome sequencing in congenital myasthenic syndromes

OBJECTIVE: To identify the genetic cause in a patient affected by ptosis and exercise-induced muscle weakness and diagnosed with congenital myasthenic syndromes (CMS) using whole-genome sequencing (WGS). METHODS: Candidate gene screening and WGS analysis were performed in the case. Allele-specific P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Azuma, Yoshiteru, Töpf, Ana, Evangelista, Teresinha, Lorenzoni, Paulo José, Roos, Andreas, Viana, Pedro, Inagaki, Hidehito, Kurahashi, Hiroki, Lochmüller, Hanns
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415388/ https://www.ncbi.nlm.nih.gov/pubmed/28508085 http://dx.doi.org/10.1212/NXG.0000000000000152

Ejemplares similares

Congenital Myasthenic Syndromes with Predominant Limb Girdle Weakness
por: Evangelista, Teresinha, et al.
Publicado: (2015)

Identification of mutations in the MYO9A gene in patients with congenital myasthenic syndrome
por: O’Connor, Emily, et al.
Publicado: (2016)

Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions
por: Nicole, Sophie, et al.
Publicado: (2017)

Congenital myasthenic syndrome with episodic apnoea: clinical, neurophysiological and genetic features in the long-term follow-up of 19 patients
por: McMacken, Grace, et al.
Publicado: (2017)

Congenital myasthenic syndrome in a cohort of patients with ‘double’ seronegative myasthenia gravis
por: Lorenzoni, Paulo José, et al.
Publicado: (2021)

Congenital Myasthenic Syndrome due to DOK7 mutations in a family from Chile
por: Bevilacqua, Jorge A., et al.
Publicado: (2017)

Mutations in MUSK causing congenital myasthenic syndrome impair MuSK–Dok-7 interaction
por: Maselli, Ricardo A., et al.
Publicado: (2010)

Targeted therapies for congenital myasthenic syndromes: systematic review and steps towards a treatabolome
por: Thompson, Rachel, et al.
Publicado: (2019)

Mitochondrial Mutations Can Alter Neuromuscular Transmission in Congenital Myasthenic Syndrome and Mitochondrial Disease
por: O’Connor, Kaela, et al.
Publicado: (2023)

Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models
por: Pugliese, Alessia, et al.
Publicado: (2023)

Long Term Follow-Up on Pediatric Cases With Congenital Myasthenic Syndromes—A Retrospective Single Centre Cohort Study
por: Della Marina, Adela, et al.
Publicado: (2020)

Salbutamol-responsive limb-girdle congenital myasthenic syndrome due to a novel missense mutation and heteroallelic deletion in MUSK
por: Gallenmüller, Constanze, et al.
Publicado: (2014)

A mutation in DOK7 in congenital myasthenic syndrome forms aggresome in cultured cells, and reduces DOK7 expression and MuSK phosphorylation in patient-derived iPS cells
por: Zhang, Shaochuan, et al.
Publicado: (2022)

Mutations in GMPPB cause congenital myasthenic syndrome and bridge myasthenic disorders with dystroglycanopathies
por: Belaya, Katsiaryna, et al.
Publicado: (2015)

A nomenclature and classification for the congenital myasthenic syndromes: preparing for FAIR data in the genomic era
por: Thompson, Rachel, et al.
Publicado: (2018)

Whole-exome sequencing identifies mutations in MYMK in a mild form of Carey-Fineman-Ziter syndrome
por: Alrohaif, Hadil, et al.
Publicado: (2018)

A novel DOK7 mutation causing congenital myasthenic syndrome with limb-girdle weakness: case series of three family members
por: Alsallum, Mohammed S., et al.
Publicado: (2021)

Intragenic duplication in the PHKD1 gene in autosomal recessive polycystic kidney disease
por: Miyazaki, Jun, et al.
Publicado: (2015)

The beta-adrenergic agonist salbutamol modulates neuromuscular junction formation in zebrafish models of human myasthenic syndromes
por: McMacken, Grace, et al.
Publicado: (2018)

Novel synaptobrevin‐1 mutation causes fatal congenital myasthenic syndrome
por: Shen, Xin‐Ming, et al.
Publicado: (2017)

Modulation of the Acetylcholine Receptor Clustering Pathway Improves Neuromuscular Junction Structure and Muscle Strength in a Mouse Model of Congenital Myasthenic Syndrome
por: Spendiff, Sally, et al.
Publicado: (2020)

Congenital myasthenic syndromes due to mutations in ALG2 and ALG14
por: Cossins, Judith, et al.
Publicado: (2013)

Congenital myasthenic syndrome with mild intellectual disability caused by a recurrent SLC25A1 variant
por: Balaraju, Sunitha, et al.
Publicado: (2019)

Congenital myasthenic syndromes
por: Finsterer, Josef
Publicado: (2019)

Role of Dok-1 and Dok-2 in Leukemia Suppression
por: Niki, Masaru, et al.
Publicado: (2004)

Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneurons
por: Jacquier, Arnaud, et al.
Publicado: (2022)

Mechanism of disease and therapeutic rescue of Dok7 congenital myasthenia
por: Oury, Julien, et al.
Publicado: (2021)

Global N-linked Glycosylation is Not Significantly Impaired in Myoblasts in Congenital Myasthenic Syndromes Caused by Defective Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1)
por: Chen, Qiushi, et al.
Publicado: (2015)

Drosophila studies support a role for a presynaptic synaptotagmin mutation in a human congenital myasthenic syndrome
por: Shields, Mallory C., et al.
Publicado: (2017)

SRSF1 and hnRNP H antagonistically regulate splicing of COLQ exon 16 in a congenital myasthenic syndrome
por: Rahman, Mohammad Alinoor, et al.
Publicado: (2015)

Dok-1 and Dok-2 are negative regulators of lipopolysaccharide-induced signaling
por: Shinohara, Hisaaki, et al.
Publicado: (2005)

Role of Dok-1 and Dok-2 in Myeloid Homeostasis and Suppression of Leukemia
por: Yasuda, Tomoharu, et al.
Publicado: (2004)

A birth of bipartite exon by intragenic deletion
por: Nozu, Kandai, et al.
Publicado: (2017)

Hearing loss, cleft palate, and congenital hip dysplasia in female carriers of an intragenic deletion of AMMECR1
por: Koene, Saskia, et al.
Publicado: (2022)

The clinical spectrum of the congenital myasthenic syndrome resulting from COL13A1 mutations
por: Rodríguez Cruz, Pedro M., et al.
Publicado: (2019)

Early neuroimaging markers of FOXP2 intragenic deletion
por: Liégeois, Frédérique J., et al.
Publicado: (2016)

Novel p62dok family members, dok-4 and dok-5, are substrates of the c-Ret receptor tyrosine kinase and mediate neuronal differentiation
por: Grimm, Jan, et al.
Publicado: (2001)

A case of early onset adenocarcinoma associated with colorectal polyposis with an unknown germline mutation
por: Zenitani, Masahiro, et al.
Publicado: (2022)

Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome
por: McMacken, Grace M, et al.
Publicado: (2019)

Intragenic deletion in the LARGE gene causes Walker-Warburg syndrome
por: van Reeuwijk, Jeroen, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_dnnrcmec8ro051pojg9etd5qo6